Background and Context
The Drugs Rules, 1945, made under the Drugs and Cosmetics Act, 1940, contain the conditions for the labelling, licensing and quality of medicines. Schedule H2 lists the medicines on whose packing a bar code or QR code is mandatory, so that a medicine's authenticity can be checked in the supply chain. The QR code contains the medicine's identification and the manufacturer's information, which software can read to identify fake or substandard medicines.
Why in the News
The Ministry of Health and Family Welfare issued Gazette notification G.S.R. 506(E) on 22 June 2026, called the "Drugs (Seventh Amendment) Rules, 2026". In it, Table 2 was added to Schedule H2, under which all vaccines, all antimicrobials, all narcotic and psychotropic medicines under the NDPS Act, and all anti-cancer medicines come. PIB gave information about this on 25 June 2026.
The Key Concept: Phased Enforcement
Rules do not come into force from publication in the Gazette itself. Per the notification, these rules will come into force from 1 July 2027, but the entry concerning antimicrobial medicines from 1 July 2028. That is, industry has been given time to prepare. As of this article's date (18 October 2026), these provisions have not yet come into force; they will come into force from future dates.
Key Facts and Figures
| Detail | Description |
|---|---|
| Notification | G.S.R. 506(E), 22 June 2026, Ministry of Health and Family Welfare; "Drugs (Seventh Amendment) Rules, 2026" (original text of the Gazette, on CDSCO's website) |
| What was added | Schedule H2's existing table was named "Table 1" and "Table 2" was added after it. Table 2's categories: (1) all vaccines; (2) all antimicrobials; (3) all narcotic and psychotropic medicines listed under the NDPS Act, 1985 and its rules; (4) all anti-cancer medicines. |
| Enforcement date | Rules applicable from 1 July 2027; serial number 2 of Table 2 (all antimicrobials) from 1 July 2028 (Gazette text). |
| From draft to final rule | Per the notification, the draft rules were published in G.S.R. 757(E) on 16 October 2025 (Gazette copies made available to the public on 18 October 2025). The final rules were made after considering objections and consulting the Drugs Technical Advisory Board. |
| The earlier arrangement | Per PIB, the QR code requirement earlier applied to the country's top 300 drug brands. |
| What is in the QR code | Per PIB, nine data elements: unique product identification code, the drug's proper and generic name, brand name, manufacturer's name and address, batch number, manufacturing date, expiry date, manufacturing licence number and details of other components. We did not see this list in the Gazette, because the notification only adds the table. |
| Purpose per PIB | Control over counterfeit and substandard medicines, stronger regulatory oversight, and better identification of fake or substandard antimicrobials in the fight against antimicrobial resistance (AMR). |
| Voluntary adoption | Per PIB, manufacturers have been encouraged to adopt it voluntarily before the notified dates. |
How the Rule Works
Legal framework: the Drugs Rules were made under Sections 12 and 33 of the Act. Before making the final rules, a draft is published and objections sought within thirty days, and the Drugs Technical Advisory Board is consulted. This process is recorded in this notification's preamble.
The method of coverage: the earlier arrangement was brand-based (top 300 brands). The new framework is category-based: "all" medicines of a category. This brings both large and small brands within its scope.
How checking will happen: per PIB, the information stored in the QR code will be readable through a software application. Which app or portal this will be is not in the PIB release or the notification.
Why This Subject Matters
The chosen categories: vaccines, antimicrobials and anti-cancer medicines are products where the harm from a fake or substandard medicine can be serious. This is our reasoning. PIB has stated the purpose as control over fake-substandard medicines and the fight related to AMR.
Narcotic drugs: PIB has linked this to the efforts of a "drug-free India". How much real effect this will have can be seen only after implementation.
Points of Debate and Cautions
Not yet in force: the notified rules will come into force from July 2027 and July 2028. So there is no evidence of their effect yet; the article only states the notified provisions.
Implementation challenges: questions such as the cost of QR codes for all vaccines, antimicrobials and anti-cancer medicines and the burden on small manufacturers are natural, but the notification or PIB has no assessment of them. This is a question for discussion, not a conclusion.
Sources and limits: we read the original text of the Gazette notification (CDSCO's Gazette list, entry 21: https://www.cdsco.gov.in/opencms/opencms/en/Notifications/Gazette-Notifications) and the PIB release (https://www.pib.gov.in/PressReleasePage.aspx?PRID=2277691&lang=2®=48). The full existing text of Schedule H2 and the QR code's technical specifications we have not read. On the first page of CDSCO's Gazette list, no later amendment on this subject was visible on 18 October 2026; we did not comb the full list.
Difference from an earlier article: we found no article on pcsmantra.com on QR codes or Schedule H2. Our article on antimicrobial resistance is The Challenge for the Health System, not on this rule.
Way Forward
Treat this article as the position of the notification of 22 June 2026. The enforcement dates (1 July 2027 and 1 July 2028) are still in the future, and the position on any change in the notification we checked only up to the first page of the CDSCO list.
Distinction in Concepts
Keep four things separate: (1) the Gazette's rule text (Table 2, dates); (2) PIB's explanation (purpose, nine data elements, the old 300-brand arrangement); (3) things still unknown (technical framework, cost, effect); and (4) our interpretations.
Mains Perspective
GS-II: health, regulatory bodies and government policies; GS-III: use of technology in governance. In your answer, keep the notification's text and your own view separate.
UPSC CSE Mains Style: Original Practice Question
On the basis of the expansion of Schedule H2 of the Drugs Rules, 1945 (22 June 2026), examine the usefulness and challenges of a track-and-trace system for medicines.
(Answer in 150 words) | 10 marks
Answer Outline
Introduction: Schedule H2 and QR codes.
Main Body: The new categories and dates; the link with fake medicines and AMR; implementation challenges.
Conclusion: Judge the usefulness of track-and-trace together with the different dates of coming into force and the readiness of implementation; do not treat the notification as an arrangement already in force or as a proven reduction in fake medicines and AMR.
Sources
- Ministry of Health and Family Welfare, Gazette notification G.S.R. 506(E), Drugs (Seventh Amendment) Rules, 2026 (22 June 2026), CDSCO's uploaded copy
- PIB, QR-code-based authentication extended to vaccines, antimicrobials, NDPS and anti-cancer medicines (25 June 2026)
The rule text is from the Gazette copy; the purpose and nine data elements from PIB. Both are government documents.
Remember: Gazette notification G.S.R. 506(E) (22 June 2026) added all vaccines, antimicrobials, NDPS medicines and anti-cancer medicines to Schedule H2. The rules will come into force from 1 July 2027, antimicrobials from 1 July 2028; that is, they have not yet come into force.
Download This Article: PDF